Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% |
|
0.00% | -93.33% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharma Services
76.7
%
| - | - | 0 | 76.7 % | - |
Patient Testing Service
23.3
%
| - | - | 0 | 23.3 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +6.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 43 | 08-12-31 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Trevor McCartney
IRO | Public Communications Contact | - | 19-02-28 |
Michael Vallone
PRN | Corporate Officer/Principal | - | 23-01-08 |
Mattia Cremona
PRN | Corporate Officer/Principal | - | 22-11-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 20-06-17 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Director of Finance/CFO | 43 | 08-12-31 | |
Danica Holley
BRD | Director/Board Member | 51 | 22-04-03 |
Yvonne Fors
BRD | Director/Board Member | 52 | 20-06-17 |
Matthew Schwartz
BRD | Director/Board Member | 50 | 22-04-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 500 | 0 | 0 | 17.39 % |
Stock B | 0 | 1,000 | 0 | 0 | |
Stock C | 1 | 6,151,499,919 | 1,069,660,735 ( 17.39 %) | 0 |
Company contact information
![address Theralink Technologies, Inc.(THER)](https://cdn.zonebourse.com/static/address/66345237.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-93.33% | 615K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- THER Stock
- Company Theralink Technologies, Inc.